Indol3-yl-carbonyl-piperidin-benzoimidazol derivatives as V1A receptor antagonists

Details for Australian Patent Application No. 2006271804 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Grundschober, Christophe; Ratni, Hasane; Bissantz, Caterina; Schnider, Patrick; Rogers-Evans, Mark

Agent Spruson & Ferguson

Pub. Number AU-B-2006271804 (Modified Examination)

PCT Pub. Number WO2007/009906

Priority 05110506.2 09.11.05 EP; 05106695.9 21.07.05 EP

Filing date 11 July 2006

Wipo publication date 25 January 2007

Acceptance publication date 31 March 2011

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/009906 Priority application(s): WO2007/009906

31 March 2011 Application Accepted

  Published as AU-B-2006271804 (Modified Examination)

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006271809-Pyrido [2 , 3-D] pyrimidine-2 , 4-diamine compounds as PTP1B inhibitors

2006271792-Peptides for use in the treatment of obesity